Kinshuk Saxena 个人学术档案 - 学术资源搜索

引用次数

	总计	2019 年至今
引用	129	46
h 指数	2	1
i10 指数	1	1

0

16

8

20102011201220132014201520162017201820192020202120222023202410 16 12 12 6 3 9 7 8 7 9 7 6 9 8

合著作者

Dr. Abdus SamadHead- Clinical Development在 novartis.com 的电子邮件经过验证
Dr. M. Intakhab AlamJazan University在 jazanu.edu.sa 的电子邮件经过验证

Kinshuk Saxena

Kinshuk Saxena

Novartis, Stryker, Ranbaxy, Rutgers

在 novartis.com 的电子邮件经过验证

Pharmaceutical commercialization


标题按引用次数排序按年份排序按标题排序	引用次数引用次数	年份
Comparison of Regulatory Aspects for the Conduct of Bioavailability and Bioequivalence Studies. S Santra, K Saxena, G Anand, SM Abdullah, T Arora International Journal of Research in Pharmacy & Science 1 (2), 2011	4	2011
Dendrimers: a class of polymers in the nanotechnology for the delivery of active pharmaceuticals A Samad, MI Alam, K Saxena Current pharmaceutical design 15 (25), 2958-2969, 2009	125	2009
Driving Change: Addressing America's Mental Health Crisis through the Power of P Kukreja, K Saxena, S Santra
Driving Change: Addressing America's Mental Health Crisis through the Power of Mobile Clinics in Underserved Communities P Kukreja, K Saxena, S Santra Harvard Public Health Review 62 (Mental Health), 2023		2023
Edition 60-Lessons from COVID-19-Building a more resilient response for the next pandemic-Health System and Drug Development perspectives-HPHR Journal P Kukreja, K Saxena, S Santra
Lessons from COVID-19: Building a More Resilient Response for the Next Pandemic P Kukreja, K Saxena, S Santra

系统目前无法执行此操作，请稍后再试。

文章 1–6

共建清朗的网络空间,如遇有害信息,请举报。
本站数据皆整合自互联网公开资源索引,方便科研学术方面查询,并不存储相关数据资源;如对此有异议,请联系我们解决.
© 2023 学术资源搜索 @联系我们 | 申请短期会员 | 数据源提交